Canaccord Genuity

QYOU Media Inc. is a global media company headquartered in Toronto, Canada, specializing in the production and distribution of content created by social media stars and digital content creators. The company operates in Canada, the United States, India, and Ireland, where it curates and produces premium content, including television networks and video on demand for cable and satellite television, as well as over-the-top (OTT) and mobile platforms. In the United States, QYOU Media also manages influencer marketing campaigns for major film studios and brands. Founded by industry veterans from prominent entertainment companies, QYOU Media focuses on delivering engaging content to millennial and Gen Z audiences, helping brands connect with younger consumers worldwide.

Avicanna Inc. is a biopharmaceutical company based in Toronto, Canada, that specializes in the research, development, and commercialization of plant-derived cannabinoid-based products for medical, consumer health, and pharmaceutical applications. Founded in 2016, Avicanna offers a range of products, including pharmaceutical-grade cannabinoids such as THC, CBD, and CBG, as well as active pharmaceutical ingredients and formulations under its Aureus Santa Marta brand. The company also develops CBD-based derma-cosmetic products under the Pura Earth brand and medical cannabis products for various health conditions, including skin disorders and neurological issues, marketed under the Rho Phyto brand. Avicanna emphasizes scientific research and has collaborations with leading academic institutions to advance its cannabinoid-based solutions. The company’s research initiatives include a focus on developing treatments for COVID-19 induced lung inflammation. With a commitment to evidence-based practices, Avicanna aims to provide innovative cannabinoid solutions to the global market.

Marathon Gold Corporation is a Canadian company focused on the acquisition, exploration, and development of mineral resource projects, primarily targeting gold and other precious and base metals. Established in 2009 and headquartered in Toronto, the company’s flagship asset is the Valentine Lake gold property located in Newfoundland and Labrador. This project encompasses a series of four mineralized deposits along a 20-kilometer system, highlighting its potential for significant mineral resources.

VitalHub is a technology company that specializes in providing solutions to health and human services providers, including hospitals, regional health authorities, and community services. Based in Toronto, Canada, with an offshore development center in Sri Lanka, VitalHub offers a range of products designed to enhance healthcare delivery. Its solutions encompass electronic health records, case management, care coordination, patient flow management, and mobile applications. The company's diverse executive and management team comprises experienced software professionals. VitalHub operates primarily within the healthcare information systems sector, serving markets in Canada, the United Kingdom, Australia, the United States, Western Asia, and beyond.

Park Lawn Corporation, founded in 1892 and headquartered in Toronto, Canada, is a provider of deathcare products and services in Canada and the United States. The company owns and operates 114 cemeteries, 39 crematoriums, and 109 funeral homes, offering a range of products including cemetery lots, crypts, niches, monuments, caskets, urns, and other memorial merchandise. Park Lawn provides these goods and services both at the time of need and on a pre-arranged basis. The company generates revenue through the sale of interment rights, cemetery services, and funeral services, with a significant portion of its income derived from its operations in the United States.

Marathon Gold Corporation is a Canadian company focused on the acquisition, exploration, and development of mineral resource projects, primarily targeting gold and other precious and base metals. Established in 2009 and headquartered in Toronto, the company’s flagship asset is the Valentine Lake gold property located in Newfoundland and Labrador. This project encompasses a series of four mineralized deposits along a 20-kilometer system, highlighting its potential for significant mineral resources.

Quinsam Capital Corporation is an investment and merchant banking firm based in Toronto, Canada, that specializes in the small-cap market with a particular emphasis on cannabis-related investments, as well as sectors such as technology, healthcare, mining, and e-sports. Founded in 2004, the company engages in various activities, including acquisitions, advisory services, lending, and portfolio investments. Quinsam seeks to invest in assets, companies, or projects that are perceived as undervalued and where there is a credible strategy for enhancing their value. This broad approach allows Quinsam to operate both domestically and internationally, positioning it to capitalize on emerging opportunities in diverse markets.

The Tinley Beverage Company Inc. is a beverage manufacturer based in Toronto, Canada, specializing in liquor-inspired, non-alcoholic beverages and cannabis-infused drinks. Established in 2007 and rebranded in 2015, the company offers a range of products, including the Tinley Tonic and Tinley 27 lines, available through retail locations primarily in California and online across the United States. Tinley Beverage focuses on crafting beverages infused with blended botanicals, natural extracts, and flavors, drawing inspiration from traditional alcoholic recipes while using premium California cannabis. Additionally, the company provides contract manufacturing services for cannabis-infused beverages, expanding its reach within the growing beverage market.

VitalHub is a technology company that specializes in providing solutions to health and human services providers, including hospitals, regional health authorities, and community services. Based in Toronto, Canada, with an offshore development center in Sri Lanka, VitalHub offers a range of products designed to enhance healthcare delivery. Its solutions encompass electronic health records, case management, care coordination, patient flow management, and mobile applications. The company's diverse executive and management team comprises experienced software professionals. VitalHub operates primarily within the healthcare information systems sector, serving markets in Canada, the United Kingdom, Australia, the United States, Western Asia, and beyond.

Slyce is a technology company specializing in visual search and image recognition solutions for retailers and brands. Founded in 2012 and based in Toronto, Ontario, Slyce offers a platform that enables users to identify products in real time through visual recognition, as well as video and audio recognition, QR and barcode scanning, and NFC technology. This platform allows retailers and brands to facilitate transactions at the moment of consumer inspiration, enhancing the shopping experience. Additionally, Slyce's services enable businesses to target new customers and optimize engagement with existing ones. The company also develops tools that harmonize data across food delivery platforms, empowering restaurants to increase their delivery revenue through machine learning and AI-driven marketing strategies. Overall, Slyce aims to simplify and enhance the shopping and dining experiences for consumers while providing valuable insights and operational efficiencies to brands and restaurants.

Aptose Biosciences Inc. is a clinical-stage biotechnology company dedicated to discovering and developing personalized therapies for unmet medical needs in oncology. The company focuses on small molecule cancer therapeutics, with a pipeline that includes APTO-253, currently in a Phase 1b trial for patients with relapsed/refractory blood cancers such as acute myeloid leukemia and high-risk myelodysplastic syndrome. Additionally, Aptose is collaborating with CrystalGenomics, Inc. on CG026806, which is in a Phase 1a/b trial for relapsed/refractory acute myeloid leukemia and various B-cell malignancies. Another partnership with OHM Oncology involves the development and commercialization of APL-581 for the treatment of hematologic malignancies. Founded in 1986 and headquartered in Toronto, Canada, Aptose Biosciences was previously known as Lorus Therapeutics Inc. and changed its name in August 2014.